Current Surgical Management for Acral Melanoma

Area of Science:

• Oncology
• Dermatology
• Cancer Research

Background:

• Acral melanoma (AM) is an aggressive skin cancer subtype with a poor prognosis.
• Historically, extensive surgery was favored, but evidence shows it does not improve survival.
• Novel therapies like immune checkpoint inhibitors and targeted drugs are changing melanoma treatment paradigms.

Purpose of the Study:

• To review the current evidence on surgical management for acral melanoma.
• To discuss the challenges and future perspectives for optimizing AM treatment strategies.
• To highlight the need for subtype-specific research due to unique molecular alterations.

Main Methods:

• Review of existing literature on acral melanoma surgical management.
• Analysis of clinical trial data and predictive modeling approaches.
• Discussion of multimodal treatment strategies incorporating novel agents and surgery.

Main Results:

• Evidence suggests that extensive surgical intervention does not improve survival in melanoma, including AM.
• Novel therapeutic agents have improved melanoma prognosis and may reduce the role of surgery.
• Predictive models integrating clinical and genomic data show promise for optimizing patient selection and surgical de-escalation.

Conclusions:

• High-level evidence for AM surgical management is limited due to its rarity in Western populations.
• The unique molecular characteristics of AM necessitate cautious application of findings from broader melanoma trials.
• Optimizing AM treatment requires multimodal approaches and further research into subtype-specific strategies.